Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
GWPH GW Pharmaceuticals plc daily Stock Chart
GWPH [NASD]
GW Pharmaceuticals plc
Healthcare | Drug Manufacturers - General | United Kingdom
statements
Index- P/E118.94 EPS (ttm)1.03 Insider Own1.12% Shs Outstand31.15M Perf Week-2.00%
Market Cap3.76B Forward P/E35.87 EPS next Y3.42 Insider Trans-83.85% Shs Float30.61M Perf Month17.69%
Income33.10M PEG- EPS next Q-0.66 Inst Own82.50% Short Float14.96% Perf Quarter19.98%
Sales392.70M P/S9.59 EPS this Y97.60% Inst Trans-0.65% Short Ratio9.13 Perf Half Y24.20%
Book/sh22.95 P/B5.35 EPS next Y418.20% ROA3.90% Target Price184.00 Perf Year-30.47%
Cash/sh16.33 P/C7.52 EPS next 5Y- ROE4.60% 52W Range67.98 - 182.05 Perf YTD17.40%
Dividend- P/FCF- EPS past 5Y19.00% ROI-15.90% 52W High-32.57% Beta1.88
Dividend %- Quick Ratio5.60 Sales past 5Y59.60% Gross Margin91.60% 52W Low80.57% ATR5.48
Employees901 Current Ratio6.50 Sales Q/Q207.70% Oper. Margin-18.90% RSI (14)63.90 Volatility4.45% 5.02%
OptionableYes Debt/Eq0.02 EPS Q/Q84.30% Profit Margin8.40% Rel Volume0.72 Prev Close125.46
ShortableYes LT Debt/Eq0.02 EarningsMay 11 AMC Payout0.00% Avg Volume501.36K Price122.75
Recom1.60 SMA206.83% SMA5020.49% SMA2007.97% Volume363,301 Change-2.16%
Apr-08-20Initiated Northland Capital Outperform $128
Mar-06-20Initiated Citigroup Buy $192
Oct-30-19Initiated H.C. Wainwright Buy $170
Oct-21-19Initiated Needham Buy $200
May-07-19Upgrade Oppenheimer Perform → Outperform
May-07-19Reiterated Guggenheim Buy $186 → $222
May-07-19Reiterated Cantor Fitzgerald Overweight $196 → $229
Mar-18-19Reiterated Cantor Fitzgerald Overweight $193 → $196
Jan-02-19Initiated JP Morgan Overweight $134
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
May-28-20 02:55PM  7 High-Risk Stocks For Market Gamblers Benzinga
11:38AM  Top Marijuana Stocks on the NASDAQ for June 2020 Investopedia
May-24-20 12:25PM  3 Top Pharma Stocks to Buy Right Now Motley Fool
May-22-20 10:26AM  Cannabis Short Sellers Down $641M In May Benzinga
May-21-20 02:59PM  GW Pharmaceuticals Looks Like It Is Ending Its Downtrend TheStreet.com
07:56AM  Cramer Gives His Opinion On GW Pharma, Bed Bath & Beyond And More Benzinga
May-13-20 06:19AM  3 Safe Cannabis Stocks to Hold During the COVID-19 Pandemic Motley Fool
May-12-20 08:06AM  The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings Benzinga
07:02AM  How GW Pharmaceuticals Hit a Home Run in Q1 Motley Fool
01:54AM  GW Pharma Pops 9% After-Hours As Epidiolex Smokes Expectations SmarterAnalyst
01:01AM  GW Pharmaceuticals PLC (GWPH) Q1 2020 Earnings Call Transcript Motley Fool
May-11-20 06:23PM  Marijuana Stock GW Pharmaceuticals Delivers Rapid Growth In Q1 Motley Fool
05:12PM  Cannabis-Focused Biotech Surges After Seizure Drug Outsells Estimates Investor's Business Daily
04:09PM  GW Pharmaceuticals sells more of CBD-derived epilepsy drug than expected, stock rises MarketWatch
04:00PM  GW Pharmaceuticals plc Reports First Quarter 2020 Financial Results and Operational Progress GlobeNewswire
May-07-20 11:17AM  What's in Store for GW Pharmaceuticals (GWPH) in Q1 Earnings? Zacks
May-06-20 06:28AM  Is It Time to Get in on GW Pharmaceuticals While the Price Is Right? Motley Fool
May-01-20 07:00AM  GW Pharmaceuticals to Present at the Bank of America Healthcare Conference 2020 GlobeNewswire
Apr-28-20 10:33AM  Cannabis Stock Rally Puts Short Sellers In The Red For 2020 Benzinga
Apr-27-20 08:09AM  How Does Investing In GW Pharmaceuticals plc (NASDAQ:GWPH) Impact The Volatility Of Your Portfolio? Simply Wall St.
Apr-21-20 02:04PM  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the First Quarter Ending March 31st, 2020 and Host Conference Call on May 11th, 2020 GlobeNewswire
08:05AM  Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors GlobeNewswire
Apr-07-20 11:11AM  DEA Deschedules Expidiolex; GW Pharma's CBD Epilepsy Treatment No Longer A Controlled Substance Benzinga +5.94%
Apr-06-20 09:00AM  GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance GlobeNewswire +5.84%
Apr-01-20 12:20PM  FDA Grants GW Pharmaceuticals Priority Review For Cannabidiol Drug In Seizure Condition Benzinga
Mar-31-20 07:00AM  GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex GlobeNewswire
Mar-24-20 04:20PM  Why This Biotech Stock And Its CBD Oil Are Immune To Coronavirus Investor's Business Daily +9.00%
Mar-20-20 07:05AM  Does GW Pharmaceuticals plc's (NASDAQ:GWPH) CEO Pay Compare Well With Peers? Simply Wall St. -5.21%
Mar-13-20 07:00AM  GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC) GlobeNewswire +8.88%
Mar-06-20 03:24PM  Medical Marijuana Investors: The Floodgates Are Opening Zacks
Mar-02-20 01:23PM  The Week In Cannabis: A Bunch Of Earnings And Policy Moves Around The World Benzinga
11:14AM  JAMA Neurology Publishes Results from Positive Phase 3 Trial of EPIDIOLEX® (cannabidiol) oral solution in Children with Seizures Associated with Dravet Syndrome GlobeNewswire
Feb-26-20 04:20PM  Why A CBD-Oil Seizure Drug Will Make Or Break This Biotech Stock Investor's Business Daily -8.59%
01:55PM  GW Pharma's Epidiolex Label Expansion, EU Launch Key Growth Drivers In 2020 Benzinga
09:36AM  The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates Benzinga
Feb-25-20 05:41PM  GW Pharma's marijuana-derived epilepsy drug sales continue to climb MarketWatch
04:01PM  GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2019 Financial Results and Operational Progress GlobeNewswire
Feb-24-20 07:00AM  GW Pharmaceuticals to Present at the Cowen 40th Annual Healthcare Conference GlobeNewswire
Feb-20-20 05:50PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
09:27AM  What's in Store for GW Pharmaceuticals' (GWPH) Q4 Earnings? Zacks
Feb-12-20 08:11AM  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Fourth Quarter and Year Ending December 31, 2019 and Host Conference Call on February 25th, 2020 GlobeNewswire
Feb-11-20 05:45PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
Feb-10-20 08:56AM  Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week Benzinga
Feb-04-20 12:02PM  BofA Sees Blockbuster Sales Potential For GW Pharma's CBD Drug Epidiolex Benzinga
08:13AM  Here's Why GW Pharmaceuticals (NASDAQ:GWPH) Can Manage Its Debt Despite Losing Money Simply Wall St.
Feb-03-20 05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
07:20AM  GW Pharma submits supplemental NDA for Epidiolex to treat seizures from TSC MarketWatch
07:00AM  GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to U.S. FDA for Epidiolex® (cannabidiol) for the Treatment of Tuberous Sclerosis Complex GlobeNewswire
Jan-31-20 12:35PM  Investors Should Forget Aurora Cannabis and Buy GWPH Stock Instead InvestorPlace
Jan-28-20 05:50PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
02:36PM  5 'Strong Buy' Biotech Stocks to Buy for 2020 Kiplinger
Jan-19-20 12:37PM  The Week In Cannabis: Stocks Rebound Hard And Many More News Benzinga
Jan-17-20 05:50PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
12:19PM  Analysts: 3 Healthcare Stocks That Could Gain 35% Or More TipRanks
Jan-16-20 12:16PM  GW Pharma Analyst Expects $475M In Sales Of CBD Drug Expidiolex This Year Benzinga
Jan-15-20 05:26PM  New Cannabis Products Which Could Disrupt the Industry in 2020 Investopedia
12:25PM  Edited Transcript of GWPH.O earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
11:14AM  A New Bill Would Remove a CBD Roadblock for Marijuana Companies Barrons.com
Jan-14-20 09:15AM  New Records Ahead of New Trade Deal and New Earnings Season Zacks
Jan-13-20 12:47PM  GW Pharmaceutical stock rallies on better-than-expected sales forecast MarketWatch +8.91%
11:38AM  Sales Keep Growing for GW Pharmas Cannabis-Based Epilepsy Treatment Barrons.com
Jan-12-20 06:00PM  GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales GlobeNewswire
Jan-08-20 04:17PM  It's the Roaring 20's, Here's our Resolutions Zacks
Jan-07-20 01:13PM  GW Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-05-20 11:24PM  Medical cannabis: dope hope Financial Times
Dec-23-19 09:34AM  Ride the Cannabis Wave With These 3 Stocks Zacks
Dec-20-19 12:04PM  The Zacks Analyst Blog Highlights: Innovative Industrial Properties, Aphria, Square and GW Pharmaceuticals Zacks
Dec-19-19 08:35AM  4 Marijuana Stocks to Play the Green Rush in 2020 Zacks
Dec-16-19 03:55PM  5 Health Care Stocks Gurus Are Buying GuruFocus.com
Dec-13-19 10:16AM  Five things you should know about Stephen Hahn, the new FDA commissioner MarketWatch
Dec-11-19 11:12AM  Cramer Advises His Viewers On GW Pharma, Enphase And More Benzinga
Dec-07-19 12:00PM  Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX® (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting GlobeNewswire
Dec-06-19 08:02AM  GW Pharmaceuticals (NASDAQ:GWPH) Shareholders Have Enjoyed A 43% Share Price Gain Simply Wall St.
Dec-05-19 07:00AM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting GlobeNewswire
Dec-01-19 09:30AM  The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More Benzinga
Nov-30-19 10:18AM  Cannabis stocks rocked as FDA warning undermines case for CBD investments MarketWatch
Nov-29-19 12:12PM  Canopy Growth will not be profitable by fiscal 2022, according to this analyst MarketWatch
Nov-27-19 01:35PM  CBD has the potential to harm you, FDA warns consumers MarketWatch
Nov-26-19 04:45PM  Brace For Stricter FDA Regulation Of CBD Consumer Products, Analysts Say Benzinga
01:07PM  Marijuana Stocks Are Slumping After the FDA Says CBD Could Harm You Barrons.com
01:07PM  CBD Has the Potential to Harm You, FDA Warns Consumers Barrons.com
07:00AM  Market Morning: CBD Warning, Chemocentryx Win, Huge Tory Majority, Amazon Injuries Market Exclusive
Nov-22-19 08:32AM  Marijuana ETFs Bounce Back: Can the Rally Last? Zacks
07:00AM  GW Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Nov-21-19 11:05AM  Cannabis Short Sellers Down $272M Following Canopy Growth Upgrade Benzinga
10:10AM  What's in the Cards for OrganiGram (OGI) in Q4 Earnings? Zacks
Nov-18-19 01:02AM  New Records and New Milestones Zacks -5.48%
Nov-17-19 01:20PM  The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization Benzinga
Nov-15-19 10:21AM  Haemonetics (HAE) Grows on New Products, Robust Plasma Sales Zacks
Nov-14-19 03:49PM  Analyst: New UK Cannabis Regulations Limit Usage, Call For Additional Research Benzinga
10:38AM  GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day Zacks
09:52AM  Here's Why You Should Hold on to CVS Health (CVS) For Now Zacks
09:39AM  CVS Health's New Plans With Aetna May Improve Health Outcomes Zacks
08:36AM  Bull of the Day: GW Pharmaceuticals (GWPH) Zacks
Nov-13-19 03:39PM  Syneos Health Collaborates with AiCure for Patient Engagement Zacks
09:56AM  Here's Why You Should Add NuVasive (NUVA) to Your Portfolio Zacks
09:46AM  Insulet Rides on Omnipod's Wider Market Reach, New Products Zacks
08:38AM  Hologic's (HOLX) 3DQuorum Imaging Technology Gets FDA Nod Zacks
07:48AM  Cronos turns lower after kicking off cannabis earnings with revenue miss MarketWatch
01:01AM  NASDAQ Hits New Record Despite Slow Session Zacks
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of glioblastoma, neonatal hypoxic-ischemic encephalopathy, and schizophrenia. Further, the company has license and development agreements with Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United Kingdom, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Knappertz VolkerChief Medical OfficerMay 18Option Exercise0.00133,620160139,092May 20 08:02 PM
Giacobello Scott M.Chief Financial OfficerMay 18Option Exercise0.00116,604140140,742May 20 08:01 PM
Giacobello Scott M.Chief Financial OfficerMar 13Buy6.807,20048,96088,224Mar 17 06:07 PM
GUY GEOFFREY W DRExecutive ChairmanMar 13Sale6.63600,0003,978,0006,221,521Mar 17 06:05 PM
Gover Justin D.Chief Executive OfficerMar 02Option Exercise0.0047,84462599,369Mar 04 06:01 PM
Snyder Douglas B.Chief Legal OfficerMar 02Sale8.322,56821,36667,296Mar 04 06:03 PM
MACKEY CATHERINE JDirectorMar 02Sale8.351,35611,32316,392Mar 04 06:04 PM
Brown CabotDirectorMar 02Sale8.243,14425,90717,088Mar 04 06:03 PM
Gover Justin D.Chief Executive OfficerMar 02Sale8.3332,856273,789566,513Mar 04 06:01 PM
Secor AliciaDirectorMar 02Sale8.341,29610,80916,440Mar 04 06:02 PM
Giacobello Scott M.Chief Financial OfficerMar 02Sale8.342,22018,51581,024Mar 04 06:00 PM
Knappertz VolkerChief Medical OfficerMar 02Sale8.323,42028,45479,392Mar 04 06:01 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Sale9.173,87635,55069,864Feb 28 06:06 PM
Gover Justin D.Chief Executive OfficerFeb 26Sale9.0512,000108,558551,525Feb 28 06:02 PM
Knappertz VolkerChief Medical OfficerFeb 26Sale9.183,01227,63682,812Feb 28 06:02 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Sale9.173,85235,32383,244Feb 28 06:01 PM
Gover Justin D.Chief Executive OfficerFeb 03Option Exercise0.00202,224263765,749Feb 05 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 03Sale9.62202,2241,944,678563,525Feb 05 05:00 PM
GUY GEOFFREY W DRExecutive ChairmanJan 15Sale9.44900,0008,493,0006,821,521Jan 17 05:00 PM
MACKEY CATHERINE JDirectorJan 03Sale8.541,53613,11717,748Jan 07 05:00 PM
Secor AliciaDirectorJan 03Sale8.531,53613,10217,736Jan 07 05:01 PM
Brown CabotDirectorJan 03Sale8.583,57630,68220,232Jan 07 05:01 PM
Gover Justin D.Chief Executive OfficerDec 17Option Exercise0.0010,66814568,865Dec 19 05:02 PM
Gover Justin D.Chief Executive OfficerDec 17Sale9.175,34048,968563,525Dec 19 05:02 PM
GUY GEOFFREY W DRExecutive ChairmanNov 11Sale9.33420,0003,918,6007,721,521Nov 13 05:00 PM
Snyder Douglas B.Chief Legal OfficerAug 19Sale13.045,42470,72973,740Aug 21 05:30 PM
Snyder Douglas B.Chief Legal OfficerAug 12Sale13.883,75652,13379,164Aug 14 05:30 PM
Waldegrave William A.DirectorJul 10Option Exercise0.003,57653,576Jul 11 09:00 PM
Waldegrave William A.DirectorJul 10Sale15.003,57653,6400Jul 11 09:00 PM
Snyder Douglas B.Chief Legal OfficerJul 09Sale14.424,96871,63982,920Jul 11 09:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Option Exercise3.2464,800209,95267,303Jun 05 08:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Sale14.6164,800946,7282,503Jun 05 08:00 PM
open in yahoo | open in reuters | open in google